Skip to main content
Terug
Watch Compare

Boundless Bio, Inc.

Datakwaliteit: 83%
BOLD
Nasdaq Manufacturing Chemicals
€ 1,15
▼ € 0,01 (-0,43%)
Marktkapitalisatie: 25,66 M
Prijs
€ 1,15
Marktkapitalisatie
25,66 M
Dagbereik
€ 1,14 — € 1,19
52-Weeksbereik
€ 0,96 — € 1,78
Volume
94.040
Openen € 1,14
50D / 200D Gem.
€ 1,14
0,05% above
50D / 200D Gem.
€ 1,18
3,24% below

Quick Summary

Belangrijkste Punten

Negative free cash flow of -47,21 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-49,98%
Boven sectorgemiddelde (-51,02%)
ROIC-30,70%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio10,14
Interest CoverageN/A

Waardering

PE (TTM)
-0,44
Boven sectorgemiddelde (-1,98)
P/B Ratio0,23
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (44 peers)
Metriek Aandeel Sector Mediaan
P/E -0,4 -2,0
P/B 0,2 5,1
ROE % -50,0 -51,0
Net Margin % — -150,2
Rev Growth 5Y % — 9,3
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -58,20 M
ROE -49,98% ROA -33,43%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -47,21 M
ROIC -30,70% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 10,14
Interest Coverage N/A Asset Turnover N/A
Working Capital 108,31 M Tangible Book Value 110,17 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,44 Forward P/E N/A
P/B Ratio 0,23 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -184,00%
Market Cap 25,66 M Enterprise Value 10,68 M
Per Share
EPS (Diluted TTM) -2,60 Revenue / Share N/A
FCF / Share -2,11 OCF / Share -2,08
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 81,12%
SBC-Adj. FCF -53,33 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue — —
Net Income -58,20 M -65,36 M
EPS (Diluted) -2,60 -3,85
Gross Profit — —
Operating Income -63,55 M -73,27 M
EBITDA — —
R&D Expenses 44,85 M 55,27 M
SG&A Expenses — —
D&A 1,25 M 1,09 M
Interest Expense — —
Income Tax 0,0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 157,06 M 206,41 M
Total Liabilities 58,41 M 55,77 M
Shareholders' Equity 98,65 M 150,64 M
Total Debt — —
Cash & Equivalents 17,87 M 26,59 M
Current Assets 109,61 M 154,39 M
Current Liabilities 12,54 M 8,14 M